S&P 500
7,633.20
+0.31%
Dow Jones
53,893.00
+1.14%
Nasdaq 100
29,106.20
+0.99%
Russell 2000
2,995.41
+0.37%
FTSE 100
10,904.40
+0.20%
Nikkei 225
64,309.90
+1.28%

Investing

WST logo West Pharmaceutical Services : WST

Price Target $444 ↑24.8%
›
Earnings Beat +13.9%
›

WST

Stock Data

$353.82

Change up

$5.22 (1.50%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

MEDICAL INSTRUMENTS & SUPPLIES

West Pharmaceutical Services Inc specializes in creating containment and delivery systems for injectable drugs and healthcare products. With a global presence, it offers a wide range of products including stoppers, seals, syringe components, and advanced drug delivery systems. The company focuses on enhancing the safety and quality of drug administration through innovative solutions like Crystal Zenith technology and self-injection devices. Serving the pharmaceutical, diagnostic, and medical device industries, West Pharmaceutical provides both proprietary and contract-manufactured products, backed by comprehensive support services from development to post-sales.

Latest Activity

WSTWest Pharmaceutical Services, Inc.
Reports Thu Jul 23Before open6:00 AM ETConfirmed

West Pharmaceutical reports Q2 earnings at 6:00 AM ET as investors hunt for evidence that booming GLP-1 demand is turbocharging sales of injectable delivery systems and stoppers.

    Read more
    WSTWest Pharmaceutical Services
    Q2 2026
    EPS
    $2.37
    est $2.08+13.9%
    Revenue
    $872M
    est $840M+3.8%

    West Pharmaceutical's GLP-1 elastomers now represent 10% of total company revenue as the obesity drug boom accelerates, and the company is raising full-year EPS guidance to $8.85 to $9.05 on surging demand for high-value injectable drug delivery components.

    Quarterly EPS — reported vs estimate
    Read more

    All West Pharmaceutical Services Articles

    24 Articles

    1 2